The creation of high-quality, innovative small molecule leads is a continual challenge in drug discovery. Against a background of increasing cost, the rate of drug discovery has remained stagnant for over 60 years. Improving research and development productivity is a considerable obstacle for the pharmaceutical sector. To address these challenges, innovative methods are crucial.
Curia addresses this in a novel way through CLC. Fill out the form to download the white paper today!
WHITE PAPER